0001529224-21-000003.txt : 20210113
0001529224-21-000003.hdr.sgml : 20210113
20210113101912
ACCESSION NUMBER: 0001529224-21-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210113
DATE AS OF CHANGE: 20210113
EFFECTIVENESS DATE: 20210113
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: GeneCentric Therapeutics, Inc.
CENTRAL INDEX KEY: 0001529224
IRS NUMBER: 452540158
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-386126
FILM NUMBER: 21525313
BUSINESS ADDRESS:
STREET 1: 100 CAPITOLA DRIVE
STREET 2: SUITE 275
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: (919) 973-6544
MAIL ADDRESS:
STREET 1: 100 CAPITOLA DRIVE
STREET 2: SUITE 275
CITY: DURHAM
STATE: NC
ZIP: 27713
FORMER COMPANY:
FORMER CONFORMED NAME: GeneCentric Diagnostics, Inc.
DATE OF NAME CHANGE: 20110902
D
1
primary_doc.xml
X0708
D
LIVE
0001529224
GeneCentric Therapeutics, Inc.
100 Capitola Drive
Suite 275
DURHAM
NC
NORTH CAROLINA
27713
(919) 973-6544
DELAWARE
GeneCentric Diagnostics, Inc.
Corporation
true
Myla
Lai-Goldman
100 Capitola Drive
Suite 275
DURHAM
NC
NORTH CAROLINA
27713
Executive Officer
Director
Michael
Milburn
100 Capitola Drive
Suite 275
DURHAM
NC
NORTH CAROLINA
27713
Executive Officer
Director
Clay
Thorp
100 Capitola Drive
Suite 275
DURHAM
NC
NORTH CAROLINA
27713
Director
Charles
Perou
100 Capitola Drive
Suite 275
DURHAM
NC
NORTH CAROLINA
27713
Executive Officer
Director
Arnold
Levine
100 Capitola Drive
Suite 275
DURHAM
NC
NORTH CAROLINA
27713
Director
Ellen
Lubman
100 Capitola Drive
Suite 275
DURHAM
NC
NORTH CAROLINA
27713
Director
Biotechnology
Decline to Disclose
- 06b
false
2020-12-29
false
true
false
0
1200000
1200000
0
false
4
0
0
0
Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.
false
GeneCentric Therapeutics, Inc.
/s/vMichael V. Milburn
Michael V. Milburn
Chief Executive Officer
2021-01-13